<b>Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison</b>

<b><i>The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. In the meantime, a pre-typeset version of the article is attached. This is not the final publication and may be subject to some minor changes.</i></b>

Publication Details

Journal
Figshare
Published
2025-09-18
DOI
https://doi.org/10.6084/m9.figshare.30147319
Primary Topic
Microwave-Assisted Synthesis and Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison

Figshare
Microwave-Assisted Synthesis and Applications
article

Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison

article en

Abstract

<b><i>The article associated with this page has been accepted for online publication and is in the final stages of production. The link to the full text will be made available on this page in the next few days. In the meantime, a pre-typeset version of the article is attached. This is not the final publication and may be subject to some minor changes.</i></b>

Figshare
Openalex Percentile: Top 47%
Microwave-Assisted Synthesis and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

<b>Dupilumab Versus Mepolizumab for COPD: Evaluating Efficacy Outcomes Using Placebo-Adjusted Indirect Treatment Comparison</b> · Figshare (2025) | TGRS Research Map | TGRS